BioSpace News Archive

Reported Positive Data from Phase 2b Clinical Trial of Topical Ocular Reproxalap in Dry Eye Disease

Continued Advancement of a New CTLA-4 Antibody with Superior Pre-clinical Qualities

Leading Healthcare Marketplace Offers Financing Options Designed to Help Customers Finance Healthcare Expenses

Precision BioSciences gains rights to MaxCyte’s cell engineering technology to develop next-generation, oncology-focused, cell therapies with Precision’s ARCUS® genome-editing technology

A new tip sheet from industry experts at Vineti and Quick provides time-proven best practices from cell and gene therapy veterans to synchronize personalized therapy supply chains and help bring more transformative treatments to more patients

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Head of Strategy, Finance, and Communication will present at the 30th Annual Piper Jaffray Healthcare Conference on November 28, 2018, at 1:50pm ET at the Lotte New York Palace in New York City.

91% of CROs taking steps to unify clinical operations for better visibility and improved study execution

Central Role for Acquist Drugs that Target Lipogenesis and Inflammation

Surna designs, engineers and manufactures application-specific environmental control and air sanitation systems for commercial, state- and provincial-regulated indoor cannabis cultivation facilities in the U.S. and Canada.

Research highlights frequency of medically actionable variants among secondary findings